Real World Evidence Solution Market Intelligence Report - Global Forecast to 2027

Real World Evidence Solution Market Intelligence Report - Global Forecast to 2027

The Global Real World Evidence Solution Market is projected to reach USD 2,319.93 million by 2027 from USD 1,078.18 million in 2021, at a CAGR 13.62% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Real World Evidence Solution Market size was estimated at USD 396.09 million in 2021 and expected to reach USD 445.44 million in 2022, at a CAGR 13.33% to reach USD 839.30 million by 2027.
• The Asia-Pacific Real World Evidence Solution Market size was estimated at USD 306.49 million in 2021 and expected to reach USD 349.68 million in 2022, at a CAGR 14.01% to reach USD 673.20 million by 2027.
• The Europe, Middle East & Africa Real World Evidence Solution Market size was estimated at USD 375.58 million in 2021 and expected to reach USD 424.81 million in 2022, at a CAGR 13.60% to reach USD 807.42 million by 2027.

Market Segmentation & Coverage:

The report on real world evidence solution identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the real world evidence solution to forecast the revenues and analyze the trends in each of the following sub-markets:

Component:

• Data Set
  • Claims Data
  • Clinical Settings Data
  • Patient-Powered Data
  • Pharmacy Data
• Services

Therapeutic Area:

• Cardiovascular
• Immunology
• Infectious Diseases
• Neurology
• Oncology

End-User:

• Biopharmaceutical Company
• Clinical & Life Sciences Organization
• Diagnostics or Medical Device Company

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Certara, L.P.
• Clinigen Group PLC
• Cognizant Technology Solutions Corp.
• HealthiVibe, LLC
• IBM Corporation
• ICON PLC
• IQVIA
• Mercy Technology Services
• Oracle Corporation
• PAREXEL International Corporation
• Pharmaceutical Product Development, LLC
• SAS Institute, Inc.
• Sciformix Corporation
• Syneos Health
• Turacoz

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 1,078.18 million

Estimated Year Value: USD 1,219.94 million

Forecast Year Value: USD 2,319.93 million

CAGR (%): 13.62%.

Please Note: PDF & Excel + Online Access - 1 Year